Long-term effect of epirubicin on incidence of heart failure in women with breast cancer: insight from a randomized clinical trial

European Journal of Heart Failure
Ann BankeBent Ejlertsen

Abstract

Anthracycline-based chemotherapy improves survival in breast cancer patients but is associated with increased risk of heart failure (HF). However, the risk of late-onset HF is debatable and mainly based on observational studies. The aim of this study was to evaluate the effect of anthracycline-based chemotherapy on long-term risk of clinical HF. Between 1990 and 1998 the Danish Breast Cancer Cooperative Group (DBCG) 89D trial randomized 980 Danish women with early breast cancer to adjuvant cyclophosphamide, epirubicin, and fluorouracil or cyclophosphamide, methotrexate, and fluorouracil. Incident HF was the primary endpoint obtained from Danish administrative registries. Follow-up ended at December 2014. The risk of HF was evaluated in a cumulative incidence analysis and a Fine-Gray proportional hazards model. Median follow-up time was 16.9 years [interquartile range (IQR) 3.7-20.9]. In the epirubicin treatment group, 23 new cases of HF were identified vs. 9 in the non-epirubicin group corresponding to incidence rates per 1000 patient-years of 3.7 [95% confidence interval (CI) 2.5-5.6] vs. 1.4 (95% CI 0.7-2.7). The cumulative incidence of HF was higher in the epirubicin treatment group compared with the non-epirubicin group (P ...Continue Reading

References

Nov 1, 1979·Annals of Internal Medicine·D D Von HoffF M Muggia
Sep 24, 2002·JAMA : the Journal of the American Medical Association·Sverre E KjeldsenUNKNOWN LIFE (Losartan Intervention for Endpoint Reduction) Study Group
Aug 12, 2004·British Journal of Cancer·J M SatagopanA D Auerbach
Jul 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark N LevineUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Oct 28, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P FumoleauUNKNOWN French Adjuvant Study Group
Feb 20, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Bent EjlertsenJonas Bergh
Jun 10, 2008·European Journal of Heart Failure·Thomas KümlerChristian Torp-Pedersen
Dec 24, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Evandro de AzambujaMartine J Piccart-Gebhart
Jul 15, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Paul McGaleMarianne Ewertz
Dec 4, 2012·Clinical Epidemiology·Sigrun Alba JohannesdottirHenrik Toft Sørensen
Mar 30, 2013·European Journal of Heart Failure·Aldo P MaggioniUNKNOWN Heart Failure Association of the European Society of Cardiology (HFA)
Jun 12, 2013·Journal of the American College of Cardiology·Clyde W YancyUNKNOWN American Heart Association Task Force on Practice Guidelines
Oct 1, 2013·The American Journal of Cardiology·Marzia LotrionteGiovanni Palazzoni
Jun 27, 2014·European Journal of Epidemiology·Morten SchmidtHenrik Toft Sørensen
Aug 30, 2014·Journal of the American College of Cardiology·Pimprapa Vejpongsa, Edward T H Yeh
Sep 1, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Evandro de AzambujaMartine Piccart-Gebhart
Nov 26, 2015·Clinical Epidemiology·Morten SchmidtHenrik Toft Sørensen

❮ Previous
Next ❯

Citations

Jul 5, 2018·European Journal of Heart Failure·Syed S MahmoodMuthiah Vaduganathan
Dec 21, 2018·ESC Heart Failure·Markus S AnkerUNKNOWN Heart Failure Association Cardio-Oncology Study Group of the European Society of Cardiology
Apr 11, 2019·European Journal of Heart Failure·Marco Metra
Dec 22, 2019·European Journal of Heart Failure·Justin L GrodinVlad G Zaha
Jun 11, 2019·Cardiac Failure Review·Edoardo BerteroChristoph Maack
Jun 5, 2020·Internal Medicine·Shingo TsujinagaToshihisa Anzai
Aug 19, 2020·European Journal of Heart Failure·José Luis ZamoranoGiorgio Minotti
May 7, 2020·Journal of Internal Medicine·C ShiR A de Boer
Oct 12, 2018·European Journal of Heart Failure·Marco Metra
Sep 19, 2020·European Journal of Heart Failure·Daniela TomasoniMarco Metra
Jan 31, 2020·ESC Heart Failure·Daniela TomasoniMarco Metra
Oct 9, 2020·Cancers·Caroline MolinaroKatia Cailliau
Dec 6, 2020·ESC Heart Failure·Daniela TomasoniMarco Metra
Nov 29, 2020·European Journal of Heart Failure·Markus S AnkerStefan D Anker
Mar 19, 2021·Journal of Cachexia, Sarcopenia and Muscle·Markus S AnkerStefan D Anker
May 25, 2021·Frontiers in Cardiovascular Medicine·Zhiwei LiJing Wang
Aug 28, 2021·European Heart Journal·Theresa A McDonaghUNKNOWN ESC Scientific Document Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Gro L WillemoeNils Brünner
© 2022 Meta ULC. All rights reserved